ACIST CVi^® Economic Value Model

The complete economic value model is a set of robust variables and calculations based on extensive research from peer-reviewed published sources. This abbreviated website version is meant to give you an idea of the value ACIST CVi^® may provide.

Total Coronary Catheterizations per Year

Enter your hospital's annual count of coronary catheterizations and click 'Next' below.

By entering the annual number of coronary catheterization procedures above, we can provide a rough estimate of the savings you/your hospital may realize by using CVi.

US procedure data showed the average break down between diagnostic versus PCI procedures was 65% to 35%¹. Meta-analysis showed average contrast use per cardiac catherization procedure with hand manifold was around 202 mL, and ACIST CVi reduced the contrast use by 22% per procedure². Additionally, the meta-analysis showed ACIST CVi^® reduced overall incidence of CI-AKI by 15%². The average annual incidence of CI-AKI is around 8.1% post PCI procedures and 11.9% post diagnostic procedures³. Average cost of contrast media is assumed to be $0.12 per mL. CI-AKI cost is around $10,459 in the model ^4,5.

US Procedure data by physicians. Data on file. Decision Resources Group (DRG) 2018
Meta-analysis of the effect of automated contrast injection devices versus manual injection and contrast volume on risk of contrast-induced nephropathy. Minsinger KD et al. Am J Cardiol. 2014;113(1) :49-53
Incidence and in-hospital Mortality of Acute Kidney Injury (AKI) and Dialysis-Requiring AKI (AKI-D) after Cardiac Catherization in the National Inpatient Sample. Brown et al. J Am Heart Assoc. 2016;5:e002739.
Incremental Cost of Acute Kidney Injury after Percutaneous Coronary Intervention in the United States Amin et al. Am J Cardiol 2020;125:29−33. 2020;125(29-33).
CPI for All Urban Consumers (CPI-U). Medical care in U.S. city average, all urban consumers, seasonally adjusted Years 2010-2020. Bureau of Labor Statistics.

Average Contrast Use with Manifold per procedure 4
Includes wasted contrast

202mL
Reduction of Contrast with ACIST CVi 4

%
Average Contrast Use with Manifold per procedure
Includes wasted contrast

mL
Average Contrast Use with Manifold per procedure

mL

References

US Procedure data by physicians. Data on file. Decision Resources Group (DRG) 2018
Meta-analysis of the effect of automated contrast injection devices versus manual injection and contrast volume on risk of contrast-induced nephropathy. Minsinger KD et al. Am J Cardiol. 2014;113(1) :49-53
Incidence and in-hospital Mortality of Acute Kidney Injury (AKI) and Dialysis-Requiring AKI (AKI-D) after Cardiac Catherization in the National Inpatient Sample. Brown et al. J Am Heart Assoc. 2016;5:e002739.
Incremental Cost of Acute Kidney Injury after Percutaneous Coronary Intervention in the United States Amin et al. Am J Cardiol 2020;125:29−33. 2020;125(29-33).
CPI for All Urban Consumers (CPI-U). Medical care in U.S. city average, all urban consumers, seasonally adjusted Years 2010-2020. Bureau of Labor Statistics.

Incidence of Contrast Induced

Acute Kidney Injury (CI-AKI)

Diagnostic

PCI

Incidence of CI-AKI with Manifold 4

15.7%

3.5%

Number of incidents of CI-AKI (Baseline)

Reduction of CI-AKI with ACIST CVi4

%

Scenario with ACIST CVi

Incidence of CI-AKI with ACIST CVi

% %

Avoided number of incidents of CI-AKI (Year 1)

Risk of Dialysis Post AKI Within 1 year9

1.7%

Estimated annual savings using ACIST CVi® (show both in terms of $$ and mL of contrast)

Disclaimer: The numbers listed above are not exact nor are they a guarantee. They are a rough estimate based on the procedure volume you provided and the assumption averages listed on the previous page. If you would like a customized estimate specific to your cath lab or hospital, please complete the form below so that your local ACIST representative can schedule time with you.

BACK

Get Your Complete Calculations

You estimated total cost savings with ACIST CVi^® could be $ per year based on reduction in contrast and CI-AKI incidence with CVi. The total length of hospital days could be reduced by days.

Want to learn more? Please provide your information below, and your ACIST representative will reach out to you to walk through the full model and discuss how ACIST's solutions may help you/your hospital save.

Full Name

Hospital Name

Email Address

Phone Number

BACK

Disclaimer: The economic model is provided for projecting possible outcomes under certain clinical and economic scenarios. The results may vary if other factors are accounted for, and therefore these results are estimates of cost savings. The information is intended to be a general reference of any cost savings. ACIST makes no guarantee that the use of products will result in exact cost savings provided here. ACIST does not intend to nor does ACIST promote the use of any products outside of their approved labeling.

ACIST CVi® Economic Value Model

Average Contrast Use with Manifold per procedure 4

Reduction of Contrast with ACIST CVi 4

%

Average Contrast Use with Manifold per procedure

mL

Average Contrast Use with Manifold per procedure

mL

References

Incidence of Contrast Induced

Incidence of CI-AKI with Manifold 4

Number of incidents of CI-AKI (Baseline)

Reduction of CI-AKI with ACIST CVi4

%

Scenario with ACIST CVi

Incidence of CI-AKI with ACIST CVi

Avoided number of incidents of CI-AKI (Year 1)

Risk of Dialysis Post AKI Within 1 year9

1.7%

Get Your Complete Calculations

Thank you for filling out the ACIST CVi Economic Value Model. A representative will be in contact with you shortly to discuss your needs!

ACIST CVi^® Economic Value Model